These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 790413

  • 1. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR, Levine J.
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
    [Abstract] [Full Text] [Related]

  • 2. Dosage and side effect comparisons betweel oral and depot fluphenazine.
    Schooler NR, Levine J.
    Psychopharmacol Bull; 1977 Jul; 13(3):29-31. PubMed ID: 329328
    [No Abstract] [Full Text] [Related]

  • 3. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 Jul; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 4. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 5. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
    Kissling W, Möller HJ, Walter K, Wittmann B, Krueger R, Trenk D.
    Pharmacopsychiatry; 1985 May; 18(3):240-5. PubMed ID: 4011672
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC, Kennedy NM, Gribbon D.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [Abstract] [Full Text] [Related]

  • 9. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 Jul; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].
    Woggon B, Dick P, Fleischhauer HJ, Gmür M, Gruber G, Angst J, Heimann H.
    Int Pharmacopsychiatry; 1977 Jul; 12(4):193-209. PubMed ID: 22515
    [Abstract] [Full Text] [Related]

  • 11. [Clinical observations of treatment with Lyorodin-depot (Jenapharm)].
    Pirozynski T, Chiriţă V, Cosmovici N, Offenberg C, Chiriac ME, Marinescu V, Cojocaru M, Berlescu M, Mungiu A.
    Rev Med Chir Soc Med Nat Iasi; 1989 Jul; 93(3):501-9. PubMed ID: 2700035
    [Abstract] [Full Text] [Related]

  • 12. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
    McLaren S, Cookson JC, Silverstone T.
    Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
    [Abstract] [Full Text] [Related]

  • 13. High vs standard dosage fluphenazine HCL in acute schizophrenia.
    Donlon PT, Meadow A, Tupin JP, Wahba M.
    J Clin Psychiatry; 1978 Nov; 39(11):800-4. PubMed ID: 363702
    [Abstract] [Full Text] [Related]

  • 14. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J, Schooler NR, Severe J, Escobar J, Gelenberg A, Mandel M, Sovner R, Steinbook R.
    Adv Biochem Psychopharmacol; 1980 Nov; 24():483-93. PubMed ID: 6996445
    [No Abstract] [Full Text] [Related]

  • 15. Side effects during long-term treatment with depot antipsychotic medication.
    Cookson JC.
    Clin Neuropharmacol; 1991 Nov; 14 Suppl 2():S24-30; discussion S30-2. PubMed ID: 1751940
    [Abstract] [Full Text] [Related]

  • 16. Stabilization and depot neuroleptic dosages.
    Weiden P, Schooler NR, Severe JB, Lee JH, Schulz SC.
    Psychopharmacol Bull; 1993 Nov; 29(2):269-75. PubMed ID: 8290676
    [Abstract] [Full Text] [Related]

  • 17. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM, Waternaux C, Chouinard G, Sommer BR, Jones B.
    J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
    [Abstract] [Full Text] [Related]

  • 18. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study.
    Donlon PT, Swaback DO, Osborne ML.
    Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967
    [Abstract] [Full Text] [Related]

  • 19. Changing from oral to depot fluphenazine.
    Yadalam KG, Simpson GM.
    J Clin Psychiatry; 1988 Sep; 49(9):346-8. PubMed ID: 3417620
    [Abstract] [Full Text] [Related]

  • 20. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B, Dogui M, Ben Ammou S, Lôo H.
    Encephale; 1995 Sep; 21(3):209-15. PubMed ID: 7649071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.